Mechanistically, HDACis may enhance the expression of major histocompatibility complex class I-related chain A and B (MICA and MICB) and UL16 binding protein (ULBp) in tumor cells, which are key NKG2D ligands (156–158). Here, KLRK1 is linked to neoplasm.